dextrothyroxine has been researched along with Break-Bone Fever in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 4 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bhattacharyya, S; Madhry, D; Malvankar, S; Phadnis, S; Srivastava, RK; Verma, B | 1 |
| Jans, DA; Wagstaff, KM | 1 |
| Ooi, EE | 1 |
| Angkasekwinai, N; Avirutnan, P; Hunnangkul, S; Komoltri, C; Mairiang, D; Malasit, P; Niwattayakul, K; Prommool, T; Puttikhunt, C; Saleh-Arong, FA; Songjaeng, A; Suputtamongkol, Y; Tangthawornchaikul, N; Thammapalo, S; Yamasmith, E | 1 |
| Han, Y; Liu, W; Pang, XY; Xu, TL; Zhang, Y; Zheng, B; Zhou, XN | 1 |
| Chan, WK; Fraser, JE; Jans, DA; Moreland, NJ; Rathore, AP; Tay, MY; Vasudevan, SG; Wang, C | 1 |
1 review(s) available for dextrothyroxine and Break-Bone Fever
| Article | Year |
|---|---|
Ivermectin as a Broad-Spectrum Host-Directed Antiviral: The Real Deal?
Topics: Animals; Antiviral Agents; Betacoronavirus; Cell Line; Chlorocebus aethiops; Coronavirus Infections; COVID-19; Dengue; Dengue Virus; HIV Infections; HIV Integrase; HIV Integrase Inhibitors; HIV-1; Humans; Ivermectin; Pandemics; Pneumonia, Viral; SARS-CoV-2; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
1 trial(s) available for dextrothyroxine and Break-Bone Fever
| Article | Year |
|---|---|
Ivermectin Accelerates Circulating Nonstructural Protein 1 (NS1) Clearance in Adult Dengue Patients: A Combined Phase 2/3 Randomized Double-blinded Placebo Controlled Trial.
Topics: Adult; Animals; Antiparasitic Agents; Dengue; Double-Blind Method; Humans; Ivermectin; Viral Nonstructural Proteins; Viremia | 2021 |
4 other study(ies) available for dextrothyroxine and Break-Bone Fever
| Article | Year |
|---|---|
Synergistic correlation between host angiogenin and dengue virus replication.
Topics: Dengue; Humans; Ivermectin; Ribonuclease, Pancreatic; Virus Replication | 2023 |
Repurposing Ivermectin as an Anti-dengue Drug.
Topics: Dengue; Dengue Virus; Drug Repositioning; Humans; Ivermectin; Pharmaceutical Preparations | 2021 |
Antivirus effectiveness of ivermectin on dengue virus type 2 in Aedes albopictus.
Topics: Aedes; Animals; Antiviral Agents; Dengue; Dengue Virus; Humans; Insecticides; Ivermectin; Mosquito Vectors; Virus Replication | 2018 |
Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin.
Topics: Antiviral Agents; Cell Nucleus; Cytoplasm; Dengue; Dengue Virus; Humans; Ivermectin; Protein Transport; Viral Nonstructural Proteins | 2013 |